振動呼気陽圧市場 - 世界の産業規模、シェア、動向、機会、予測、タイプ別、用途別、地域別、競合別、2020年～2030年

振動呼気陽圧の世界市場規模は、2024年に1億4,231万米ドルとなり、予測期間には1億9,808万米ドルに達すると予測され、2030年までのCAGRは5.64%です。

世界の振動呼気陽圧（OPEP）市場は、ヘルスケア分野で著しい成長と変貌を遂げています。OPEP装置は、慢性閉塞性肺疾患（COPD）、喘息、嚢胞性線維症、気管支拡張症など、さまざまな呼吸器疾患の管理に不可欠なツールとして登場しています。これらの機器は、呼気時に振動抵抗を与えることで作動し、気道からの粘液の排出を促進し、肺機能を高め、最終的には呼吸器系の健康を改善します。市場の拡大は主に、世界規模での呼吸器疾患の有病率の上昇によって推進されています。

呼吸器疾患の有病率の増加

世界の振動呼気陽圧（OPEP）市場は、呼吸器疾患の世界の有病率の憂慮すべき増加により、大幅な成長を遂げています。例えば、慢性閉塞性肺疾患（COPD）は、2021年に世界で約2億1,339万人が罹患し、年齢標準化された有病率は年々上昇しています。もう一つの重要な呼吸器疾患である喘息は、2019年には推定2億6,200万人に影響を与え、同年の死亡者数は4億5,500万人に上りました。

環境汚染、タバコ喫煙、ライフスタイルの変化などの要因が、これらの疾患の発生率上昇に寄与しています。世界保健機関（WHO）の報告によると、高所得国ではCOPD患者の70％以上、低・中所得国では30％から40％をタバコ喫煙が占めています。呼吸器疾患の負担が増加の一途をたどる中、効果的な治療法の開発が急務となっています。

OPEP装置は、これらの呼吸器疾患を管理するための、非侵襲的で薬剤を使用しないソリューションとして登場しました。呼気時に振動抵抗を与えることで、気道からの粘液の排出を助け、肺機能の改善と呼吸器全般の健康増進につながります。広範な呼吸器疾患に対応するこの有効性が、OPEP装置に対する高い需要を牽引しています。さらに、患者やヘルスケア専門家は、従来の薬物介入に伴う限界や潜在的な副作用を認識するようになってきています。このため、ホリスティックで低侵襲な治療への選好が変化し、市場におけるOPEP装置の魅力をさらに高めています。したがって、OPEP世界市場の成長は呼吸器疾患の急増と密接に関連しています。これらの疾患が世界人口の一部に影響を及ぼし続けていることから、OPEP装置のような非侵襲的で薬剤を使用しない効果的な呼吸器治療に対する需要が高まっています。呼吸器疾患を管理するための革新的なソリューションを提供する市場の役割はかつてないほど重要であり、世界中でこれらの疾患と闘っている数え切れないほどの人々に希望と呼吸器の健康改善を提供しています。

主要な市場課題

規制上のハードルとコンプライアンス

主要市場動向

技術の進歩

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の振動呼気陽圧市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • タイプ別（フェイスマスク型OPEP装置、マウスピース型OPEP装置、ボトル型OPEP装置）
  • 用途別（喘息、無気肺、気管支炎、その他）
  • 企業別（2024年）
  • 地域別
• 市場マップ

第6章 北米の振動呼気陽圧市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • メキシコ
  • カナダ

第7章 欧州の振動呼気陽圧市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋の振動呼気陽圧市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 韓国
  • 日本
  • オーストラリア

第9章 南米の振動呼気陽圧市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの振動呼気陽圧市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第13章 PESTEL分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• D-R Burton Healthcare
• Monaghan
• ICU Medical, Inc
• Allergan
• Trudell Medical International
• CEGLA Medizintechnik GmbH & Co. KG
• Medica Holdings, LLC
• AirPhysio
• PARI GmbH
• GaleMed Corporation

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Oscillatory Positive Expiratory Pressure Market was valued at USD 142.31 Million in 2024 and is expected to reach USD 198.08 Million in the forecast period with a CAGR of 5.64% through 2030. The Global Oscillatory Positive Expiratory Pressure (OPEP) Market is experiencing remarkable growth and transformation within the healthcare sector. OPEP devices have emerged as indispensable tools for managing a wide range of respiratory conditions, including chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, and bronchiectasis. These devices operate by providing oscillatory resistance during exhalation, facilitating the clearance of mucus from airways, enhancing lung function, and ultimately improving respiratory well-being. The market's expansion is primarily propelled by the escalating prevalence of respiratory disorders on a global scale.

Increasing Prevalence of Respiratory Disorders

The Global Oscillatory Positive Expiratory Pressure (OPEP) Market is experiencing substantial growth, driven by the alarming increase in the prevalence of respiratory disorders worldwide. Chronic obstructive pulmonary disease (COPD), for instance, affected approximately 213.39 million people globally in 2021, with an age-standardized prevalence that has been rising over the years. Asthma, another significant respiratory condition, impacted an estimated 262 million individuals in 2019 and was responsible for 455,000 deaths that year.

Factors such as environmental pollution, tobacco smoking, and changing lifestyles have contributed to the rising incidence of these ailments. The World Health Organization (WHO) reports that tobacco smoking accounts for over 70% of COPD cases in high-income countries and 30-40% in low-and-middle-income countries. As the burden of respiratory diseases continues to grow, there is a pressing need for effective treatment options.

OPEP devices have emerged as a non-invasive and drug-free solution to manage these respiratory conditions. By providing oscillatory resistance during exhalation, they aid in the clearance of mucus from the airways, leading to improved lung function and enhanced overall respiratory health. This effectiveness in addressing a wide spectrum of respiratory disorders has driven the high demand for OPEP devices. Moreover, patients and healthcare professionals are increasingly recognizing the limitations and potential side effects associated with traditional pharmaceutical interventions. This has led to a shift in preference toward holistic and minimally invasive treatments, further boosting the appeal of OPEP devices in the market. The Global OPEP Market's growth is therefore intricately linked to the surging prevalence of respiratory disorders. As these conditions continue to affect a growing portion of the global population, the demand for non-invasive, drug-free, and effective respiratory treatments like OPEP devices is set to rise. The market's role in providing innovative solutions for managing respiratory ailments has never been more critical, offering hope and improved respiratory health to countless individuals grappling with these conditions worldwide.

Key Market Challenges

Regulatory Hurdles and Compliance

Navigating the labyrinth of regulatory requirements is a formidable challenge for OPEP device manufacturers. These devices are subject to stringent quality and safety standards, which can vary significantly from one region to another. In the United States, for instance, OPEP devices fall under the purview of the Food and Drug Administration (FDA), necessitating rigorous testing and documentation to gain approval. In Europe, the European Medicines Agency (EMA) oversees regulatory compliance, adding to the complexity for manufacturers seeking to market their products globally.

Meeting regulatory standards demands substantial resources in terms of time, money, and manpower. Manufacturers must conduct extensive testing, compile comprehensive documentation, and engage in protracted approval processes. The time it takes for a device to move from concept to market can be discouraging, impeding innovation and delaying patient access to advanced OPEP technologies. The intricate regulatory landscape can be particularly daunting for smaller companies and startups in the OPEP market. The costs associated with compliance, coupled with the lengthy approval timelines, can act as a significant barrier to entry. As a result, the market may become dominated by larger, well-established manufacturers, limiting diversity and stifling potential innovation.

Key Market Trends

Technological Advancements

In the constantly evolving realm of medical technologies, the Global Oscillatory Positive Expiratory Pressure (OPEP) Market stands out, with technological advancements acting as a cornerstone for its rapid growth. OPEP devices, designed to improve lung function and overall respiratory health, have been beneficiaries of continuous innovation, making them more effective, user-friendly, and versatile. One of the standout technological trends is the miniaturization of OPEP devices. Modern devices have become more compact and portable without sacrificing their efficacy. This has been a game-changer for patients, allowing them to integrate OPEP therapy seamlessly into their daily lives, be it at home, work, or on-the-go, thereby ensuring consistent treatment adherence. The integration of smart technology and digital connectivity in OPEP devices is another remarkable advancement. Today's devices often come equipped with features that allow patients to monitor their respiratory metrics in real-time, offering insights into their treatment progress. These smart devices can also connect to smartphones and other digital platforms, enabling data sharing with healthcare providers. Such connectivity ensures that medical professionals can monitor their patients remotely, adjusting treatment plans as necessary and providing timely interventions. Usability enhancements are also evident in the latest OPEP devices. Intuitive interfaces, clear instructional guides, and ergonomic designs make these devices more patient-friendly, especially for older adults or those less familiar with medical devices. Such improvements have led to increased patient compliance, ultimately leading to better health outcomes.

Key Market Players

• D-R Burton Healthcare
• Monaghan
• ICU Medical, Inc
• Allergan
• Trudell Medical International
• CEGLA Medizintechnik GmbH & Co. KG
• Medica Holdings, LLC
• AirPhysio
• PARI GmbH
• GaleMed Corporation

Report Scope:

In this report, the Global Oscillatory Positive Expiratory Pressure Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oscillatory Positive Expiratory Pressure Market, By Type:

• Facemask OPEP Devices
• Mouthpiece OPEP Devices
• Bottle OPEP Devices

Oscillatory Positive Expiratory Pressure Market, By Application:

• Asthma
• Atelectasis
• Bronchitis
• Other

Oscillatory Positive Expiratory Pressure Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oscillatory Positive Expiratory Pressure Market.

Available Customizations:

Global Oscillatory Positive Expiratory Pressure market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Oscillatory Positive Expiratory Pressure Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Facemask OPEP Devices, Mouthpiece OPEP Devices, Bottle OPEP Devices)
  • 5.2.2. By Application (Asthma, Atelectasis, Bronchitis, Other)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Oscillatory Positive Expiratory Pressure Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Oscillatory Positive Expiratory Pressure Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Oscillatory Positive Expiratory Pressure Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Oscillatory Positive Expiratory Pressure Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application

7. Europe Oscillatory Positive Expiratory Pressure Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Oscillatory Positive Expiratory Pressure Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Oscillatory Positive Expiratory Pressure Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Oscillatory Positive Expiratory Pressure Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Oscillatory Positive Expiratory Pressure Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Oscillatory Positive Expiratory Pressure Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application

8. Asia-Pacific Oscillatory Positive Expiratory Pressure Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Oscillatory Positive Expiratory Pressure Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
  • 8.3.2. India Oscillatory Positive Expiratory Pressure Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Oscillatory Positive Expiratory Pressure Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Oscillatory Positive Expiratory Pressure Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Oscillatory Positive Expiratory Pressure Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application

9. South America Oscillatory Positive Expiratory Pressure Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Oscillatory Positive Expiratory Pressure Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Oscillatory Positive Expiratory Pressure Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Oscillatory Positive Expiratory Pressure Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application

10. Middle East and Africa Oscillatory Positive Expiratory Pressure Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Oscillatory Positive Expiratory Pressure Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Oscillatory Positive Expiratory Pressure Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Oscillatory Positive Expiratory Pressure Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1 D-R Burton Healthcare
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Monaghan
• 15.3. ICU Medical, Inc
• 15.4. Allergan
• 15.5. Trudell Medical International
• 15.6. CEGLA Medizintechnik GmbH & Co. KG
• 15.7. Medica Holdings, LLC
• 15.8. AirPhysio
• 15.9. PARI GmbH
• 15.10. GaleMed Corporation

16. Strategic Recommendations

17. About Us & Disclaimer